These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 23127735)

  • 1. Clostridium difficile infection: new insights into management.
    Khanna S; Pardi DS
    Mayo Clin Proc; 2012 Nov; 87(11):1106-17. PubMed ID: 23127735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Individualized treatment strategies for Clostridium difficile infections].
    Solbach P; Dersch P; Bachmann O
    Internist (Berl); 2017 Jul; 58(7):675-681. PubMed ID: 28589214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
    Biswas JS; Patel A; Otter JA; Wade P; Newsholme W; van Kleef E; Goldenberg SD
    J Hosp Infect; 2015 Jul; 90(3):267-70. PubMed ID: 25728208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of Clostridium difficile infection.
    Dupont HL
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin.
    Tannock GW; Munro K; Taylor C; Lawley B; Young W; Byrne B; Emery J; Louie T
    Microbiology (Reading); 2010 Nov; 156(Pt 11):3354-3359. PubMed ID: 20724385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of Clostridium difficile treatments: a systematic review.
    Drekonja DM; Butler M; MacDonald R; Bliss D; Filice GA; Rector TS; Wilt TJ
    Ann Intern Med; 2011 Dec; 155(12):839-47. PubMed ID: 22184691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clostridium difficile infecion--diagnostics, prevention and treatment].
    Piekarska M; Wandałowicz AD; Miigoć H
    Pol Merkur Lekarski; 2014 Apr; 36(214):278-82. PubMed ID: 24868904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fidaxomicin--the new drug for Clostridium difficile infection.
    Vaishnavi C
    Indian J Med Res; 2015 Apr; 141(4):398-407. PubMed ID: 26112840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison.
    Cornely OA; Nathwani D; Ivanescu C; Odufowora-Sita O; Retsa P; Odeyemi IA
    J Antimicrob Chemother; 2014 Nov; 69(11):2892-900. PubMed ID: 25074856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile: the emerging epidemic.
    Safdar N
    Mayo Clin Proc; 2012 Nov; 87(11):1037-9. PubMed ID: 23127729
    [No Abstract]   [Full Text] [Related]  

  • 13. Fidaxomicin versus vancomycin for Clostridium difficile infection.
    Louie TJ; Miller MA; Mullane KM; Weiss K; Lentnek A; Golan Y; Gorbach S; Sears P; Shue YK;
    N Engl J Med; 2011 Feb; 364(5):422-31. PubMed ID: 21288078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical inquiries. What are effective therapies for Clostridium difficile-associated diarrhea?
    Ohl ME; Stevermer JJ; Meadows S; Tribuna J; Chek K
    J Fam Pract; 2005 Feb; 54(2):176-8. PubMed ID: 15689297
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic approaches for Clostridium difficile infections.
    Marsh JW; Curry SR
    Curr Protoc Microbiol; 2013 Oct; 30():9A.3.1-9A.3.9. PubMed ID: 24510892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial therapy of Clostridium difficile infection. Systematic review and meta-analysis of the scientific evidence].
    Brodszky V; Gulácsi L; Ludwig E; Prinz G; Banai J; Reményi P; Strbák B; Kertész A; Kopcsóné Németh I; Zsoldiné Urbán E; Baji P; Péntek M
    Orv Hetil; 2013 Jun; 154(23):890-9. PubMed ID: 23728312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and Treatment of Clostridium difficile Infection.
    Gupta A; Cifu AS; Khanna S
    JAMA; 2018 Sep; 320(10):1031-1032. PubMed ID: 30178042
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenges and opportunities in the management of Clostridium difficile infection.
    DuPont HL
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):863-74. PubMed ID: 25012255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile Infection in Children.
    Alvarez AM; Rathore MH
    Adv Pediatr; 2019 Aug; 66():263-280. PubMed ID: 31230698
    [No Abstract]   [Full Text] [Related]  

  • 20. Firvanq--vancomycin oral solution.
    Med Lett Drugs Ther; 2018 Jul; 60(1551):122. PubMed ID: 30036349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.